NM_000059.4(BRCA2):c.8557A>T (p.Lys2853Ter) AND Breast-ovarian cancer, familial, susceptibility to, 2
- Germline classification:
- Pathogenic (1 submission)
- Last evaluated:
- Dec 15, 2017
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000661783.1
Allele description [Variation Report for NM_000059.4(BRCA2):c.8557A>T (p.Lys2853Ter)]
NM_000059.4(BRCA2):c.8557A>T (p.Lys2853Ter)
Condition(s)
-
tetraspanin-12 isoform X1 [Homo sapiens]
tetraspanin-12 isoform X1 [Homo sapiens]gi|530385679|ref|XP_005250296.1|Protein
-
Grania postclitellochaeta voucher SMNH<SWE>:107740 cytochrome oxidase subunit I ...
Grania postclitellochaeta voucher SMNH<SWE>:107740 cytochrome oxidase subunit I (COI) gene, partial cds; mitochondrialgi|311700760|gb|GU473653.1|Nucleotide
-
Grania postclitellochaeta isolate PDW76 internal transcribed spacer 1, partial s...
Grania postclitellochaeta isolate PDW76 internal transcribed spacer 1, partial sequence; 5.8S ribosomal RNA gene, complete sequence; and internal transcribed spacer 2, partial sequencegi|311700831|gb|GU473713.1|Nucleotide
-
Mus musculus prospero homeobox 2 (Prox2), transcript variant 2, mRNA
Mus musculus prospero homeobox 2 (Prox2), transcript variant 2, mRNAgi|1360422499|ref|NM_001361238.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Oct 20, 2024